Collectively, VSV-S not only enhances CD8+ T cell-mediated antitumor immunity by inducing PANoptosis in HNSCC cells but also reverses T cell exhaustion by suppressing the expression of the key immune checkpoint regulator PDL1 in HNSCC cells (Fig. 7J). The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.